XML 59 R47.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Values (Tables)
12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Schedule of assets and liabilities recorded at fair value on a recurring and non-recurring basis
The following fair value hierarchy table summarizes the Company's assets and liabilities recorded at fair value on a recurring and non-recurring basis by the above categories ($ in thousands):
  Fair Value Using
 TotalQuoted market
prices in
active markets
(Level 1)
Significant other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
As of December 31, 2020    
Recurring basis:
Derivative liabilities(1)
18,926 — 18,926 — 
Available-for-sale securities(1)
25,274 — — 25,274 
Non-recurring basis:    
Impaired land and development(2)
6,078 — — 6,078 
As of December 31, 2019    
Recurring basis:    
Derivative assets(1)
$114 $— $114 $— 
Derivative liabilities(1)
8,680 — 8,680 — 
Available-for-sale securities(1)
$23,896 $— $— $23,896 
Non-recurring basis:    
Impaired land and development(3)
40,000 — — 40,000 
_______________________________________________________________________________
(1)The fair value of the Company's derivatives are based upon widely accepted valuation techniques utilized by a third-party specialist using observable inputs such as interest rates and contractual cash flow and are classified as Level 2. The fair value of the Company's available-for-sale securities are based upon unadjusted third-party broker quotes and are classified as Level 3.
(2)The Company recorded a $1.3 million impairment on a land and development asset with an estimated fair value of $6.1 million. The fair value is based on future cash flows expected to be received.
(3)The Company recorded aggregate impairments of $5.3 million on two land and development assets with an estimated aggregate fair value of $40.0 million. The estimated fair values are based on expected sales proceeds.
Summary of changes in Level 3 available-for-sale securities reported at fair value The following table summarizes changes in Level 3 available-for-sale securities reported at fair value on the Company's consolidated balance sheets for the years ended December 31, 2020 and 2019 ($ in thousands):
20202019
Beginning balance$23,896 $21,661 
Repayments(460)(45)
Unrealized gains recorded in other comprehensive income1,838 2,280 
Ending balance$25,274 $23,896 
Schedule of Carrying Value and Fair Value of Financial Instruments The following table presents the carrying value and fair value for the Company's financial instruments ($ in millions):
As of December 31, 2020As of December 31, 2019
Carrying
Value
Fair
Value
Carrying
Value
Fair
Value
Net investment in leases(1)
$429 $431 $419 $419 
Loans receivable and other lending investments(1)
732 772 828 864 
Cash and cash equivalents(2)
99 99 307 307 
Restricted cash(2)
52 52 45 45 
Loan participations payable, net(1)
43 43 36 36 
Debt obligations, net(1)
3,287 3,414 3,387 3,531 
_______________________________________________________________________________
(1)The fair value of the Company's net investment in leases, loans receivable and other lending investments, net, loan participations payable, net and debt obligations, net are classified as Level 3 within the fair value hierarchy.
(2)The Company determined the carrying values of its cash and cash equivalents and restricted cash approximated their fair values. Restricted cash is recorded in "Deferred expenses and other assets, net" on the Company's balance sheet. The fair value of the Company's cash and cash equivalents and restricted cash are classified as Level 1 within the fair value hierarchy.